Erythrocyte sedimentation rate (ESR) analyzer measures the rate, at which the red blood cells or erythrocytes settle in a period of one hour. ESR is usually measured in millimeter per hour (mm/hour). An extremely high ESR value, which is one above 100 mm/hour may indicate the diseases such as multiple myeloma, hypersensitivity vasculitis, and temporal arteritis. ESR analyzer is a common hematological tester, which detects the non-specific inflammation, caused by active infection, cancer, heart disease, kidney disease, blood disease, diabetes, and collagen vascular disease. These analyzers are used in hospitals to measure the sedimentation rate of erythrocytes and red blood cells for reliable and accurate reading. The fully automated ESR analyzers are enable to give the fully automatic analysis of ESR. Semi-Automated ESR analyzers are not fully automatic rather certain operations of those instruments require manual intervention. The advantage of these instruments include smaller size, due to which they can be used in constrained spaces.

Global ESR Analyzer Market - Drivers

Increasing number of infections leading to various health hazards will contribute to increasing number of ESR tests, which in turn will drive the global ESR analyzer market. According to the World Health Organization, in 2018, healthcare associated infection was about 10% and surgical site infections were 50%. ESR is one of the basic hematological test, which is performed to identify various disease conditions that would contribute to growth of global ESR analyzer market. Technological upgrades leading to development of automated ESR analyzers would also contribute to the global ESR analyzer market growth.

Furthermore, adoption of advanced semi-automatic and automatic ESR analyzers in the healthcare industry are among the prime factors driving the global ESR analyzer market growth. On the other hand, requirement of lesser workforce and is ultimately fueling the global ESR analyzer market growth. Increase in usage of ESR analyzers in hospitals, diagnostic laboratories, and academic institutions drives growth of the global ESR analyzer market.

Moreover, manufacturers are developing advanced systems such as automated ESR analyzers to provide instant detection rate. For instance, in July 2018, Streck and Diesse Diagnostica Senese introduced the Cube 30 Touch, an automated instrument for high volume erythrocyte sedimentation rate testing in Ethylene diamine tetraacetic acid (EDTA) tubes. The analyzer produces ESR results directly from EDTA tubes without consuming the patient sample. Furthermore, in September 2013, Beckman Coulter, Inc., and IRIS Diagnostics announced the launch of the Alifax automated erythrocyte sedimentation rate (ESR) analysis system through a distribution agreement with Alifax S.r.l.

Key players in the global ESR analyzer market are adopting distribution agreements that allow the company to enhance revenue in various regions. For instance, in March 2017, Sysmex America signed a distribution agreement with Alifax S.r.l. for its erythrocytes sedimentation rate products. Alifax ESR analyzers are an exciting addition in the Sysmex portfolio. In response to the market needs for quick results, the Alifax Test1 and Roller 20, a family of automated analyzers, offer ESR results in 20 seconds.

Global ESR Analyzer Market - Regional Insights

North America holds dominant position in the global ESR analyzer market, owing to increasing incidence of blood related diseases and presence of majority of the manufacturers in this region.

Asia Pacific is expected to gain the highest growth rate during the forecast period, owing to increasing blood borne infections, and inadequate sanitation conditions, which lead to increase infections among population. Moreover, government focuses on the improvement in healthcare infrastructure and providing the better healthcare facilities to the population, which would propel growth of global ESR analyzer market in Asia Pacific.

Global ESR Analyzer Market - Competitive Landscape

Some of the key players operating in the global ESR analyzer market include ALCOR Scientific Inc., Thermo Fisher Scientific, Caretium Medical Instruments Co., LTD, Hospitex Diagnostics, Beckman Coulter Inc., Alifax, Perlong Medical, Streck, Diesse Diagnostica Senese S.p.A, and ELITech Group.

Key Development

In November, 2019 Beckman Coulter, Inc., and IRIS Diagnostics, entered into a distribution agreement with Alifax S.r.l and launched Alifax automated Erythrocyte Sedimentation Rate (ESR) analysis system.
In September 2019, Alcor Scientific, launched miniiSED, a single position fully automated erythrocyte sedimentation rate (ESR) analyzer.
In 2018, Streck Inc., introduced CUBA 30 touch, an automated instrument for high-volume erythrocyte sedimentation rate testing in EDTA tubes
In 2017, System America, Inc., announced that it has signed a distribution agreement with Alifax S.r.l. for its erythrocyte sedimentation rate (ESR) products.

Global ESR Analyzer Market - Market Taxonomy

On the basis of product type, the global ESR analyzer market is segmented into: